Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines

Endocrinology

Volumn 141, Issue 10, 2000, Pages 3687-3695

  Colson, Anne ^a   Le Cam, Alphonse ^b   Maiter, Dominique ^a   Edery, Marc ^c   Thissen, Jean Paul ^a,d  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d Diabetes and Nutrition Unit   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; GROWTH HORMONE; INTERLEUKIN 1BETA; JANUS KINASE; LIPOPOLYSACCHARIDE; RNA; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATABOLISM; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONE RESISTANCE; LIVER; LIVER CELL CULTURE; MALE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; SIGNAL TRANSDUCTION;

EID: 0033752093     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.10.7724     Document Type: Article

References (51)

1. Second Annual Jonathan E. Rhoads Lecture. The metabolic response to injury and its nutritional implications: Retrospect and prospect
2. Septic autocannibalism. A failure of exogenous nutritional support
3. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism
4. Insulin-like growth factor-I production is inhibited in human sepsis
5. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I
6. Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system
7. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease
8. Anabolic effect of recombinant human growth hormone in patients with wasting associated human immunodeficiency virus infection
9. Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man
10. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1
11. Regulation of insulin-like growth factor- I (IGF-I) and IGF binding proteins by tumor necrosis factor
12. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors
13. Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
14. Contrasting effects of growth hormone and insulin-like growth factor I on the biological activities of endotoxin in the rat
15. Proinflammatory cytokines interleukin 1β and tumor necrosis factor a inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells
16. The SOCS proteins: A new family of negative regulators of signal transduction
17. A family of cytokineinducible inhibitors of signalling
18. Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion
19. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
20. Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat
21. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
22. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction
23. Cis desensitizes GH induced Stat5 signaling in rat liver cells
24. Differential regulation of IGF-I and IGFBP-1 mRNAs by amino acid availability and growth hormone in rat hepatocyte primary culture
25. Evidence that pretranslational and translational defects decrease serum IGF-I concentrations during dietary protein restriction
26. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5
27. Prolactin activates tyrosyl phosphorylation of insulin receptor substrate 1 and phosphatidylinositol-3-OH kinase
28. A new protein containing an SH2 domain that inhibits JAK kinases
29. Structure and function of a new STAT-induced STAT inhibitor
30. The role of SOCS-3 in leptin signaling and leptin resistance
31. Down-regulation of liver JAK2STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation
32. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin
33. LPS and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages
34. The interleukin 1 receptor: Ligand interactions and signal transduction
35. A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL-1β gene
36. Interleukin-1β activates a short STAT-3 isoform is clonal insulin-secreting cells
37. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2containing protein 1 transgenic mice
38. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
39. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
40. cis-acting elements controlling transcription from rat serine protease inhibitor 2.1 gene promoter. Characterization of two growth hormone response sites and a dominant purine-rich element
41. Binding of STAT5a and STAT5b to a single element resembling a γ-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells
42. Transcription of the rat serine protease inhibitor 2.1 gene in vivo: Correlation with GAGA box promoter occupancy and mechanism of cytokine-mediated down-regulation
43. Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1β in vitro
44. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo
45. Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor
46. Suppression of interleukin-3 induced gene expression by a C-terminal truncated STAT-5: Role of STAT-5 in proliferation
47. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: A distinct biochemical difference between STAT5A and STAT5B
48. Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes
49. Interleukin-6-type cytokine signalling through the gpl30/Jak/STAT pathway
50. Regulation of Spi 2.1 and 2.2 gene expression after turpentine inflammation: Discordant responses to IL-6
51. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6